Predictheon — Seed · €1.8M

Predictheon, an IDIBAPS/Hospital Clínic spin-off building an AI platform that predicts anaesthesia-related complications during surgery, closed a €1.8M round to advance towards commercialisation and clinical trials. No lead was formally declared, though Grow Venture Partners contributed the largest share, deploying capital from the Catalan public fund FITA and the EIF; regulatory approval could take up to two years with market entry targeted from 2028.